Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study-Reference-Cited by-同舟云学术

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

Published:2021-04-22 Issue:6 Volume:38 Page:2990-3002
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Ansari Ejaz^ORCID,Pavicic-Astalos Jasna,Ayan Filis,King Anthony J.,Kinsella Matthew,Ng Eugene,Nita Anca,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-01725-7.pdf

Reference18 articles.

1. International Council of Ophthalmology. Guidelines for glaucoma care. 2016. http://www.icoph.org/downloads/ICOGlaucomaGuidelines.pdf. Last Accessed 13 May 2020.

2. Prum BE Jr, Rosenberg LF, Gedde SJ, et al. Primary open-angle glaucoma Preferred Practice Pattern(®) guidelines. Ophthalmology. 2016;123(1):P41-p111.

3. Glaucoma: diagnosis and management. NICE guideline. 2017. https://www.nice.org.uk/guidance/ng81/resources/glaucoma-diagnosis-and-management-pdf-1837689655237. Last Accessed 22 Sept 2020.

4. European Glaucoma Society. Terminology and guidelines for glaucoma. 2014. https://www.eugs.org/eng/egs_guidelines_download.asp. Last Accessed 13 May 2020.

5. Barnebey HS, Robin AL. Adherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trial. Am J Ophthalmol. 2017;176:61–9.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glaucoma Disease Classification by using Fundus images;Bulletin of Business and Economics (BBE);2024-03-25

2. Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability;Expert Opinion on Drug Safety;2022-10-03

3. A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia;Clinical Ophthalmology;2022-08

4. Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy;Clinical Ophthalmology;2022-06

5. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment;Advances in Therapy;2022-05-07